|
HLA-DP Antigens
|
D23.050.705.552.450.400.420 |
|
|
Pyrrolizidine Alkaloids
|
D03.633.100.772 |
|
|
Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins
|
D12.776.157.530.625 |
|
|
Amaurosis Fugax
|
C11.966.075.125 |
|
|
Neuroepithelial Cells
|
A11.671.650.915.500.530 |
|
|
Glycolipids
|
D006017 |
[Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage)
] |
|
Glycols
|
D006018 |
[A generic grouping for dihydric alcohols with the hydroxy groups (-OH) located on different carbon atoms. They are viscous liquids with high boiling points for their molecular weights.
] |
|
Glycolysis
|
D006019 |
[A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH.
, An old term for glycolysis. Often it is used to describe anaerobic glucose catabolism that includes the further conversion of PYRUVIC ACID to LACTIC ACID or ETHANOL.
] |
|
Chemokine CCL11
|
D12.644.276.374.200.110.550 |
|
|
Glycogen Storage Disease Type VI
|
D006013 |
[A hepatic GLYCOGEN STORAGE DISEASE in which there is an apparent deficiency of hepatic phosphorylase (GLYCOGEN PHOSPHORYLASE, LIVER FORM) activity.
] |
|
Glycogen Storage Disease Type VII
|
D006014 |
[An autosomal recessive glycogen storage disease in which there is deficient expression of 6-phosphofructose 1-kinase in muscle (PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE) resulting in abnormal deposition of glycogen in muscle tissue. These patients have severe congenital muscular dystrophy and are exercise intolerant.
] |
|
Glycogen Storage Disease Type VIII
|
D006015 |
[An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon.
] |
|
Independent Practice Associations
|
N03.219.521.576.343.800.450 |
|
|
Managed Care Programs
|
N03.219.521.576.343.800 |
|
|
Glycolates
|
D006016 |
[Derivatives of ACETIC ACID which contain an hydroxy group attached to the methyl carbon.
] |
|
TRPC6 Cation Channel
|
D12.776.157.530.400.150.850 |
|
|
Glycopeptides
|
D006020 |
[Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight.
] |
|
Wool Fiber
|
D000078623 |
[Filament, thread, or yarn produced from WOOL.
] |
|
Glycophorins
|
D006021 |
[The major sialoglycoprotein of human erythrocyte membranes. It consists of at least two sialoglycopeptides and is composed of 60% carbohydrate including sialic acid and 40% protein. It is involved in a number of different biological activities including the binding of MN blood groups, influenza viruses, kidney bean phytohemagglutinin, and wheat germ agglutinin.
] |
|
beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase
|
D006022 |
[An enzyme that catalyzes the transfer of galactose from UDP-galactose to a specific glycoprotein receptor, 2-acetamido-2-deoxy-D-glucosyl-glycopeptide, during glycopeptide synthesis. EC 2.4.1.38.
] |
